Merck & Co., Inc. (LON: 0QAH)

London flag London · Delayed Price · Currency is GBP · Price in USD
89.70
0.00 (0.00%)
Jul 21, 2022, 7:10 PM BST
-14.90%
Market Cap 197.28B
Revenue (ttm) 47.13B
Net Income (ttm) 9.06B
Shares Out n/a
EPS (ttm) 3.57
PE Ratio 21.77
Forward PE n/a
Dividend 2.43 (2.45%)
Ex-Dividend Date Dec 16, 2024
Volume 2,180
Open 89.29
Previous Close 89.70
Day's Range 89.29 - 95.07
52-Week Range 84.53 - 119.56
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Feb 4, 2025

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M−M−R II, Variv... [Read more]

Sector Healthcare
Founded 1891
Employees 72,000
Stock Exchange London Stock Exchange
Ticker Symbol 0QAH
Full Company Profile

Financial Performance

In 2023, Merck & Co.'s revenue was $60.12 billion, an increase of 1.40% compared to the previous year's $59.28 billion. Earnings were $365.00 million, a decrease of -97.49%.

Financial numbers in USD Financial Statements

News

There is no news available yet.